CRT 23 Late-Breaking Science Video Collection
Published: 17 March 2023
-
Views:
225
-
Likes:
7
-
Views:
225
-
Likes:
7
-
4m 19sPart 1 | Session 1 PCI Vs CABG in Left Main Coronary Artery Disease With or Without Diabetes: A Pooled Analysis Prakriti Gaba
-
7m 6sPart 1 | Session 2 vFFr vs FFR Guided Revascularization in Patients with Coronary Artery Disease: The FAST III Trial Joost Daemen
Overview
For short, concise coverage of the key data released at CRT 2023, our accessible Expert Interviews were conducted with select faculty, focussing on the results, applicability and impact on future research.
More from this programme
Part 1
Expert Interviews
About the episode
CRT 23 - In this short interview, we are joined by Dr Bernardo Cortese (Ospedale Fate bene Fratelli, IT) to outline the findings from a prespecified sub-analysis of the EASTBOURNE study. In this trial, investigators aimed to evaluate the performance of a sirolimus-coated balloon to treat coronary lesions. This sub-analysis collected and analysed 73 patients where 2/3 of their lesions were type A and 1/3 were type B.
Questions:
1. What is the background of this study?
2. What are the specifications of this sub-analysis of the EASTBOURNE study?
3. What was the patient population and study design?
4. What are the key findings?
5. What should be the impact of these findings on clinical practice and future research?
6. What are the next steps?
Recorded remotely from Milan, 2023.
Editor: Jordan Rance
Videography: Oliver Miles and Dan Brent
Faculty Biographies
Bernardo Cortese
Dr Bernardo Cortese is Consultant Interventional Cardiologist for coronary and structural heart disease at the Columbus Clinic in Milano, and the Vercelli Hospital in Italy. He is the CEO of the DCB Academy, and Director of Cardiology at Clinical San Carlo in Milano.
Comments